Nvidia will open Cambridge-1 supercomputing to UK healthcare startups
At present, the most powerful supercomputer in the UK is Cambridge-1. This is a $100 million project invested by NVIDIA. It will be committed to promoting the development of the medical industry. Researchers and scientists can use artificial intelligence to accelerate biological research. Nvidia has already cooperated with AstraZeneca, GSK, Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, and Oxford Nanopore Technologies. The first batch of projects includes an in-depth understanding of brain diseases such as dementia, the use of artificial intelligence to assist in the development of new drugs, and the improvement of the accuracy of research on finding pathogenic variants in the human genome.
Image: Nvidia
Recently, following the 10-year plan to promote the research and implementation of artificial intelligence technology in the United Kingdom, NVIDIA announced that it will open the Cambridge-1 supercomputer to UK healthcare startups. David Hogan, vice president of Enterprise EMEA at NVIDIA, said, “Today is an important step in furthering the U.K.’s strategic advantage as a global leader in AI. NVIDIA is proud to support the U.K.’s AI ecosystem with Cambridge-1, the country’s most powerful supercomputer, and our Inception programme that includes more than 500 of the U.K.’s most dynamic AI startups.”
“Access to the compute power of Cambridge-1 will be a game changer in our effort to fuse computation with laboratory experiments to change the way protein drugs are engineered,” said Dr. Kamil Tamiola, Peptone CEO and founder. “We plan to use Cambridge-1 to vastly improve the design of antibodies to help treat numerous inflammatory diseases.”
